US Patent Issued to Quoin Pharmaceuticals on Sept. 1 for "Combination treatment for Netherton syndrome" (Virginia Inventors)

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,721,834, issued on Sept. 1, was assigned to Quoin Pharmaceuticals Inc. (Ashburn, Va.).

"Combination treatment for Netherton syndrome" was invented by Michael Myers (Ashburn, Va.) and Denise Carter (Ashburn, Va.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to methods of treating Netherton syndrome. In one embodiment, the method comprises administering to the patient (i) a serine protease inhibitor and (ii) an anti-inflammatory agent. In another embodiment, the method comprises (a) administering to the patient a serine protease inhibitor and an anti-inflammatory agent when the patient is having an outbreak of Netherton synd...